IMU

0.00%

4.8¢ imugene limited

Charting Only., page-699

First 699 Last

Share
Profile

Follow
kates9999

15,344 Posts.

687

22/11/19

14:46

Post #: 41580847
Share

Originally posted by karthur ↑

Kate, firstly I have always appreciated your evidence based views especially in Charting, second I'm not adept at charting and not a trader I haven't used "Twiggs Money Flow". I have gone to the trouble of "googling it and see it can be used to fine tune trading entry and exit points.

In respect of the recent activity I suspect it is largely trading based as there haven't been any significant holder notice changes over the last 1-2 weeks despite a very large increase in trading volumes. Unless of course there are mechanisms for trading accumulation of parcels of shares by a single entity under multiple different ownership entities. I assume that may be possible at scale for institutional investors but not retail investors?.

The recent changes in Money Flow seem quite volatile, as opposed to the prior periods in the chart which have the appearance of more prolonged/directional moves. The recent period suggests to me difficulties in "price discovery", as if the market is trying to assess true value?. This would fit with the uncertainty about acquisition of the Oncovirus platforms perhaps?.

I would also observe that most of the recent dips in Money Flow have been pretty short lived, the 3.1-3.8 range, and 4.1-4.8 range for example.
The TMF suggests to me there continues to be sustained levels of buying. So maybe there is accumulation going on but if that is happening I would have expected to see a change in holding notice?.

The TMF chart doesn't have the "unloved" appearance June 2019 and early October 2019.

Anyway appreciate your expertise, Im not one for dropping in and out of IMU although I appreciate its been very tradable for many here.
With respect to Pharma interest the EGM outcome was a significant risk mitigation milestone, and has seen the rerating of IMU by the market.

Apologies this post contains no charts!!!.

Karthur

Expand

good post
if it hit 10c Pharma isn't going anywhere near this without CF33 trial data/human proof of concept (if valued at 4.2c without) at a 350 m market cap
VLA went for 500 in late phase 2 with Merck with solid data

when it breathes and the day traders get bored and go away you will get a much better sense of what is going on - personally I think 10c would be a bit of a disaster for a buy out at this stage but thats just me

Last edited by kates9999: 22/11/19

IMU Price at posting: 5.8¢ Sentiment: Hold Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 1,827 more messages in this thread...

First 699 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change 0.000(0.00%)		Mkt cap ! $356.9M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.8¢	$328.5K	6.792M

Buyers (Bids)

No.	Vol.	Price($)
45	5443565	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	2171910	5

View Market Depth

No.	Vol.	Price($)
45	5443565	0.048
43	4562182	0.047
49	3188200	0.046
61	6392230	0.045
12	2001364	0.044

Price($)	Vol.	No.
0.049	2171910	5
0.050	4756889	17
0.051	6179811	13
0.052	2579418	10
0.053	1158504	8

Last trade - 16.10pm 04/10/2024 (20 minute delay)

IMU (ASX) Chart

Charting Only., page-699

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Charting Only., page-699

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News